Cabaron, Azaleah Reign D.
HRN: 26-40-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2024
CEFUROXIME 750MG (VIAL)
12/22/2024
12/28/2024
IV
330mg
Q8h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes